Concourse Financial Group Securities, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$31.06 - $39.3 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	BUY	$36.21 - $45.78 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$42.07 - $57.72 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	SELL	$40.21 - $59.36 $120 - $178	-3 Closed	0 $0
Q2 2024 Jul 23, 2024	BUY	$37.42 - $51.61 $112 - $154	3 New	3 $0
Q1 2024 Apr 30, 2024	BUY	$43.02 - $53.69 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$31.73 - $49.19 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$34.92 - $46.66 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	SELL	$34.92 - $46.66 $453 - $606	-13 Closed	0 $0
Q2 2023 Aug 10, 2023	BUY	$37.35 - $52.15 $485 - $677	13 New	13 $0
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$33.72 - $46.33 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$39.96 - $66.14 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$45.8 - $85.4 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$62.2 - $84.4 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$73.71 - $87.86 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$77.92 - $102.4 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$106.9 - $167.73 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$84.4 - $177.39 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$33.8 - $62.9 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$42.5 - $63.11 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$54.93 - $74.36 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.81 - $90.15 $0 - $0	0 New	0 $0

Others Institutions Holding RARE

# of Institutions

362

Shares Held

91.1M

Call Options Held

3.65M

Put Options Held

2.26M

Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$324 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$179 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

4.01M
Shares

$128 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

3.94M
Shares

$126 Million
0.43% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.89M
Shares

$92.2 Million
0.01% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.24B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account